"Antimetabolites" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033)
| Descriptor ID |
D000963
|
| MeSH Number(s) |
D27.505.519.186 D27.888.569.042
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antimetabolites".
Below are MeSH descriptors whose meaning is more specific than "Antimetabolites".
This graph shows the total number of publications written about "Antimetabolites" by people in this website by year, and whether "Antimetabolites" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 2 | 3 |
| 2019 | 1 | 1 | 2 |
| 2020 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Antimetabolites" by people in Profiles.
-
Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer. JAMA Oncol. 2021 11 01; 7(11):1686-1691.
-
[RNA polymerase: The Achilles heel of SARS-CoV-2]. Med Sci (Paris). 2021 03; 37(3):288-292.
-
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19. J Med Virol. 2021 05; 93(5):3176-3183.
-
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro. mBio. 2021 01 19; 12(1).
-
Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection? Autophagy. 2020 12; 16(12):2123-2127.
-
Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations. Biomed Res Int. 2020; 2020:6237160.
-
Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report. Front Endocrinol (Lausanne). 2020; 11:554.
-
Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials. Virus Res. 2020 10 15; 288:198137.
-
COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis. 2020 Dec; 22(6):e13427.
-
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Antiviral Res. 2020 06; 178:104793.